Ever Source Wealth Advisors, LLC Autolus Therapeutics PLC Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,564 shares of AUTL stock, worth $2,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,564
Previous 6,112
74.41%
Holding current value
$2,658
Previous $9,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
164MCall Options Held
0Put Options Held
39.3K-
Wellington Management Group LLP Boston, MA27.1MShares$46.1 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$34.8 Million0.22% of portfolio
-
Mak Capital One LLC New York, NY17MShares$28.8 Million5.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT16.9MShares$28.6 Million1.36% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$28.3 Million98.24% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $155M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...